Dr. Moratti is an interventional radiologist at Hospital Israelita Albert Einstein in São Paulo, Brazil, specializing in image-guided minimally invasive percutaneous procedures, with a focus on thoracic oncologic and lymphatic interventions. His clinical work emphasizes the integration of multimodality imaging to optimize complex procedures, including tumor ablation and advanced lymphatic interventions. He is also actively involved in education, leading initiatives to integrate lymphatic medicine into undergraduate medical and nursing training programs, as well as participating as a speaker in national and international conferences.

He is particularly motivated by the opportunity to improve the diagnosis and treatment of lymphatic disorders, a field that remains underrecognized and underserved. His work is driven by the goal of expanding access to minimally invasive therapies and increasing awareness of lymphatic diseases among healthcare professionals.

Dr. Goldenberg is a board-certified plastic surgeon specializing in craniofacial and pediatric plastic surgery, with extensive experience in vascular anomalies. He is an Associate Professor (Private Docent) in the Department of Surgery at the University of São Paulo Medical School. He serves as Director of Pediatric Plastic Surgery and the Vascular Anomalies Clinic at Hospital das Clínicas, University of São Paulo, and as Chief of the Plastic Surgery and Craniofacial Surgery Teams at Hospital Israelita Albert Einstein. He is also a co-author of the latest ISSVA classification of vascular anomalies and serves as Vice President-elect of the society.

His work is deeply driven by the complexity and impact of vascular anomalies, particularly in pediatric patients. He is committed to advancing multidisciplinary care and improving long-term outcomes through innovation, education, and collaboration in the field of vascular anomalies.

Dr. Rodrigo Gobbo Garcia is a physician specialized in medical imaging, interventional radiology, and interventional oncology. He leads the Center of Interventional Medicine and Interventional Oncology at Hospital Israelita Albert Einstein in São Paulo, Brazil. He serves as Director of Interventional Oncology at the Brazilian Society of Interventional Radiology and Endovascular Surgery (SOBRICE). He holds a PhD focused on the cost-effectiveness of minimally invasive treatments and has extensive experience in the development and implementation of innovative medical technologies. Internationally, he serves as a member of the Strategic and Technical Advisory Group on Medical Devices (STAG-MEDEV) at the

World Health Organization. His work is centered on advancing access to high-quality, image-guided therapies and integrating innovation into healthcare systems.

He is motivated by the potential of technology and minimally invasive therapies to transform patient care at scale, contributing to more efficient, accessible, and high-quality healthcare delivery.

Dr. Murilo Marques A. Silva is a radiologist dedicated to lymphatic imaging and advanced diagnostic techniques. His work focuses on the development and clinical application of imaging methods that improve the characterization of lymphatic disorders and support precise interventional planning.

With a strong interest in advancing the understanding of lymphatic diseases, Dr. Silva contributes to more accurate diagnosis, better patient stratification, and more informed therapeutic decision-making. His practice is guided by the goal of establishing lymphatic imaging as an essential component of comprehensive patient care.

Dr. Priscila Mina Falsarela is a vascular surgeon at Hospital Israelita Albert Einstein in São Paulo, Brazil, where she works at the Center of Interventional Medicine. She holds a PhD from Einstein and serves as Coordinator of the Research Center. Her clinical practice focuses on the management of patients with lymphedema and other lymphatic disorders, with additional expertise in the evaluation and treatment of lipedema.

She is motivated by the significant impact of lymphatic diseases on patients’ quality of life and is dedicated to improving care pathways through research, innovation, and multidisciplinary collaboration. Her work emphasizes a patient-centered approach and the expansion of access to specialized care.